22,310
edits
Changes
Jump to navigation
Jump to search
m
using Template:MD
{{Citation
|Title=When inquired about their involvement, an intactivist received this response
|Text=This is in response to your email dated June 30, 2010, to Dr. Francis S. Collins, M.D.{{MD}}, Ph.D., Director of the National Institutes of Health (NIH), concerning clinical trial #NCT01115335l, “Feasibility, Acceptability, and Safety of Neonatal Male Circumcision in Lusaka, Zambia,” and the premise upon which it was designed. That is, that circumcision prevents the transmission of HIV infection. Your email has been forwarded to the National Institute of Allergy and Infectious Diseases (NIAID), the NIH component with primary responsibility for research on HIV/AIDS.
The World Health Organization/Joint United Nations Program on HIV/AIDS has concluded that the research evidence that male circumcision is efficacious in reducing sexual transmission of HIV from women to men is compelling, and that it has been proven beyond reasonable doubt. (http://data.unaids.org/pub/Report/2007/mc_recommendations_en.pdf) Their report and additional information is available on male circumcision for HIV prevention at www.malecircumcision.org. This Web site/clearinghouse is a service of the World Health Organization (WHO), the Joint United Nations Programme on HIV/AIDS (UNAIDS), the AIDS Vaccine Advocacy Coalition (AVAC), and Family Health International (FHI).
== Continuing advocating for more circumcision ==
From a National HIV Vaccine Awareness Day statement dated 18 May 2011 by Anthony S. Fauci, M.D.{{MD}}, Director of NIAID (emphasis added):<ref>{{REFweb |last=Anthony S. Fauci, M.D. {{MD}}, Director, National Institute of Allergy and Infectious Diseases National Institutes of Health
|first=
|date=2011-05